MIRA Pharmaceuticals (MIRA) News Today $1.38 -0.07 (-4.83%) Closing price 04:00 PM EasternExtended Trading$1.42 +0.04 (+2.54%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MIRA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period MIRA Pharmaceuticals Reports Positive Ketamir-2 Study Results4 hours ago | tipranks.comMira Pharmaceuticals shareholders approve acquisition of SKNY PharmaceuticalsSeptember 12 at 1:42 PM | msn.comMIRA Pharmaceuticals Approves 2022 Omnibus Incentive PlanSeptember 11, 2025 | tipranks.comWall Street Zen Downgrades MIRA Pharmaceuticals (NASDAQ:MIRA) to SellSeptember 7, 2025 | americanbankingnews.comMira Pharmaceuticals completes Phase 1 SAD portion for oral Ketamir-2August 20, 2025 | msn.comMIRA Pharmaceuticals Completes Phase 1 Trial for Ketamir-2August 19, 2025 | tipranks.comMIRA Pharmaceuticals’ Ketamir-2 Shows Promising Preclinical ResultsAugust 12, 2025 | msn.comMIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine ...August 12, 2025 | finance.yahoo.comMira announces acceptance of second Ketamir-2 manuscript for publicationAugust 12, 2025 | msn.comMIRA Pharmaceuticals Announces Virtual Annual Meeting to Discuss SKNY MergerAugust 9, 2025 | msn.comMIRA Pharmaceuticals Gets FDA Clearance for Ketamir-2 TrialsJuly 28, 2025 | tipranks.comMIRA Pharmaceuticals Reports Promising SKNY-1 Preclinical ResultsJuly 10, 2025 | tipranks.comCannabinoid Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 10, 2025 | uk.finance.yahoo.comMira Pharmaceuticals raises $2 million through at-the-market stock saleJuly 9, 2025 | investing.comMIRA Pharmaceuticals Raises $2M Through Stock SaleJuly 8, 2025 | tipranks.comMIRA Pharmaceuticals: MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving ... - FinanzNachrichten.deJuly 2, 2025 | finanznachrichten.deMIRA Data Shows Improved Weight Loss PotentialJuly 1, 2025 | finance.yahoo.comEXCLUSIVE: MIRA Pharmaceuticals' Soon To Be Acquired Weight Loss Drug Reverses Obesity Markers And Cuts Nicotine Craving In Animal StudyJune 30, 2025 | finance.yahoo.comMIRA Pharmaceuticals Announces New Data Underscoring Potential of SKNY-1 - A Drug Candidate Pending Acquisition - To Disrupt Weight Loss and Smoking Cessation Markets Without ...June 26, 2025 | finanznachrichten.deMIRA Announces Positive Test Results from AcquisitionJune 26, 2025 | finance.yahoo.comMIRA Gets Validation from JournalJune 18, 2025 | finance.yahoo.comMIRA Pharmaceuticals’ Ketamir-2 Published in Pharmacology JournalJune 17, 2025 | tipranks.comMIRA Pharmaceuticals Appoints New Chief Financial OfficerMay 21, 2025 | tipranks.comMIRA Releases Financials as Research ContinuesMay 15, 2025 | finance.yahoo.comMIRA Pharmaceuticals board approves SKNY Pharmaceuticals acquisition; combined value tops $60MMay 9, 2025 | msn.comMIRA Pharma Stock Soars To 2-Month High On $60M SKNY Deal: Retail Sentiment StrongMay 9, 2025 | msn.comMIRA Pharmaceuticals Acquires SKNY Pharmaceuticals for $60MMay 8, 2025 | tipranks.comMIRA Sets Up Success With Stellar Safety ResultsMay 6, 2025 | msn.comMira Pharmaceuticals reports in vitro drug release data for topical Ketamir-2April 24, 2025 | markets.businessinsider.comMIRA Pain Treatment Expands Market Size PotentialApril 23, 2025 | msn.comPharmaceutical Stock Jumps After Key Trial FindingsApril 17, 2025 | msn.comMira Pharmaceuticals announces results for Ketamir-2 in diabetic neuropathyApril 17, 2025 | markets.businessinsider.comMira Pharma Leads Healthcare Buzz Surge On Promising Oral Ketamine Analog Preclinical TrialApril 17, 2025 | msn.comMIRA Continues Positive Testing RunApril 16, 2025 | msn.comEXCLUSIVE: MIRA Pharmaceuticals Ketamir-2 Shows Efficacy In Diabetes-Associated Nerve Damage In Animal StudyApril 16, 2025 | finance.yahoo.comMira Pharmaceuticals enrolls first subjects in Phase 1 trial of Ketamir-2April 2, 2025 | markets.businessinsider.comMIRA Enrolls Patients Amid Rapid ProgressApril 2, 2025 | msn.comMira Pharmaceuticals signs binding LOI to acquire SKNY PharmaceuticalsMarch 25, 2025 | markets.businessinsider.comMIRA Pharmaceuticals in binding LOI to acquire SKNY PharmaceuticalsMarch 25, 2025 | markets.businessinsider.comMira Pharmaceuticals expands Ketamir-2 development with topical treatmentMarch 13, 2025 | markets.businessinsider.comMIRA Makes Another Pain Management StrideMarch 13, 2025 | msn.com1MIRA : EXCLUSIVE: MIRA Pharmaceuticals Expands Pipeline, Enhances Value Proposition...March 13, 2025 | benzinga.comMira Pharmaceuticals announces approval, initiation of Phase 1 Ketamir-2 trialMarch 4, 2025 | markets.businessinsider.comMIRA Announces Approval of Important TestingMarch 4, 2025 | msn.comEXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic PainMarch 4, 2025 | finance.yahoo.comRising High: Exclusive talk with pharmaceutical development company MIRAJanuary 16, 2025 | markets.businessinsider.comHere's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn SituationJanuary 5, 2025 | finance.yahoo.comMIRA Pharmaceuticals submits IND to FDA for Ketamir-2December 21, 2024 | markets.businessinsider.comMIRA Makes Major StridesDecember 19, 2024 | msn.comErez Aminov Sells 55,410 Shares of MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) StockNovember 28, 2024 | insidertrades.com Get MIRA Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MIRA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MIRA Media Mentions By Week MIRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MIRA News Sentiment▼0.890.94▲Average Medical News Sentiment MIRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MIRA Articles This Week▼51▲MIRA Articles Average Week Get the Latest News and Ratings for MIRA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MIRA Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Oncolytics Biotech News Today HilleVax News Today Coya Therapeutics News Today Surrozen News Today Cassava Sciences News Today Adagene News Today KALA BIO News Today Atossa Genetics News Today eXoZymes News Today Alto Neuroscience News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MIRA) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MIRA Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MIRA Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MIRA Stock Alerts